HALO logo

Halozyme Therapeutics (HALO) Gross margin

annual gross margin:

84.30%+7.50%(+9.77%)
December 31, 2024

Summary

  • As of today (June 22, 2025), HALO annual gross profit margin is 84.30%, with the most recent change of +7.50% (+9.77%) on December 31, 2024.
  • During the last 3 years, HALO annual gross margin has risen by +2.66% (+3.26%).
  • HALO annual gross margin is now -15.31% below its all-time high of 99.54%, reached on December 31, 2011.

Performance

HALO Gross margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALOprofitability metrics

quarterly gross margin:

81.73%-4.16%(-4.84%)
March 31, 2025

Summary

  • As of today (June 22, 2025), HALO quarterly gross profit margin is 81.73%, with the most recent change of -4.16% (-4.84%) on March 31, 2025.
  • Over the past year, HALO quarterly gross margin has dropped by -3.81% (-4.45%).
  • HALO quarterly gross margin is now -18.23% below its all-time high of 99.95%, reached on September 30, 2011.

Performance

HALO quarterly gross margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALOprofitability metrics

Gross margin Formula

Gross Margin =  Gross Profit
Revenue
✕ 100%

HALO Gross margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+9.8%-4.5%
3 y3 years+3.3%-5.4%
5 y5 years+9.8%+5.9%

HALO Gross margin Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+9.8%-5.4%+9.5%
5 y5-yearat high+9.8%-10.7%+9.5%
alltimeall time-15.3%+135.7%-18.2%+4543.8%

HALO Gross margin History

DateAnnualQuarterly
Mar 2025
-
81.73%(-4.8%)
Dec 2024
84.30%(+9.8%)
85.89%(+3.5%)
Sep 2024
-
82.96%(+0.1%)
Jun 2024
-
82.88%(-3.1%)
Mar 2024
-
85.54%(+10.7%)
Dec 2023
76.80%(-2.7%)
77.27%(+3.6%)
Sep 2023
-
74.62%(-3.5%)
Jun 2023
-
77.35%(-1.2%)
Mar 2023
-
78.31%(+2.0%)
Dec 2022
78.90%(-3.4%)
76.79%(-0.7%)
Sep 2022
-
77.36%(-0.5%)
Jun 2022
-
77.72%(-10.1%)
Mar 2022
-
86.42%(+9.6%)
Dec 2021
81.64%(-2.6%)
78.84%(-6.1%)
Sep 2021
-
83.95%(+1.0%)
Jun 2021
-
83.13%(+4.5%)
Mar 2021
-
79.53%(+1.4%)
Dec 2020
83.79%(+9.2%)
78.41%(-14.3%)
Sep 2020
-
91.48%(+2.1%)
Jun 2020
-
89.61%(+16.1%)
Mar 2020
-
77.18%(+12.0%)
Dec 2019
76.76%(-17.8%)
68.91%(+33.3%)
Sep 2019
-
51.69%(-45.7%)
Jun 2019
-
95.21%(+3.7%)
Mar 2019
-
91.84%(+1.3%)
Dec 2018
93.33%(+3.5%)
90.67%(-7.1%)
Sep 2018
-
97.55%(-0.1%)
Jun 2018
-
97.63%(+8.3%)
Mar 2018
-
90.11%(-6.2%)
Dec 2017
90.16%(+16.5%)
96.05%(+10.5%)
Sep 2017
-
86.93%(+13.0%)
Jun 2017
-
76.92%(+3.3%)
Mar 2017
-
74.49%(-6.3%)
Dec 2016
77.36%(-1.3%)
79.48%(+11.4%)
Sep 2016
-
71.32%(-5.0%)
Jun 2016
-
75.08%(-8.1%)
Mar 2016
-
81.74%(-2.5%)
Dec 2015
78.35%(+12.2%)
83.86%(+19.4%)
Sep 2015
-
70.26%(-13.5%)
Jun 2015
-
81.23%(+24.6%)
Mar 2015
-
65.21%(-18.2%)
Dec 2014
69.83%
79.76%(+23.1%)
DateAnnualQuarterly
Sep 2014
-
64.80%(-4.4%)
Jun 2014
-
67.78%(+25.8%)
Mar 2014
-
53.87%(-24.8%)
Dec 2013
88.60%(-9.1%)
71.68%(-25.1%)
Sep 2013
-
95.73%(+5.1%)
Jun 2013
-
91.12%(-2.8%)
Mar 2013
-
93.76%(-3.3%)
Dec 2012
97.42%(-2.1%)
97.00%(+1.3%)
Sep 2012
-
95.75%(-2.5%)
Jun 2012
-
98.16%(-0.9%)
Mar 2012
-
99.05%(+1.4%)
Dec 2011
99.54%(+7.3%)
97.67%(-2.3%)
Sep 2011
-
99.95%(+0.7%)
Jun 2011
-
99.23%(-0.6%)
Mar 2011
-
99.84%(+32.9%)
Dec 2010
92.77%(-5.1%)
75.12%(-24.7%)
Sep 2010
-
99.79%(+2.5%)
Jun 2010
-
97.40%(-2.4%)
Mar 2010
-
99.84%(+2.4%)
Dec 2009
97.72%(+1.6%)
97.52%(+0.9%)
Sep 2009
-
96.61%(-0.2%)
Jun 2009
-
96.84%(-3.0%)
Mar 2009
-
99.85%(+4.2%)
Dec 2008
96.21%(+2.7%)
95.84%(+1.2%)
Sep 2008
-
94.69%(-2.8%)
Jun 2008
-
97.41%(-0.5%)
Mar 2008
-
97.94%(+0.1%)
Dec 2007
93.67%(+68.8%)
97.82%(+4.4%)
Sep 2007
-
93.69%(+4.9%)
Jun 2007
-
89.34%(-1.4%)
Mar 2007
-
90.59%(+0.3%)
Dec 2006
55.49%(-6.2%)
90.29%(+5030.1%)
Sep 2006
-
1.76%(-98.0%)
Jun 2006
-
86.18%(+25.5%)
Mar 2006
-
68.67%(+9.6%)
Dec 2005
59.15%(+65.4%)
62.67%(+3.3%)
Sep 2005
-
60.65%(+12.3%)
Jun 2005
-
54.00%(-27.0%)
Dec 2002
-
74.01%(-5.6%)
Sep 2002
-
78.36%(+1626.0%)
Jun 2002
-
4.54%(-95.0%)
Mar 2002
-
90.32%
Dec 2001
35.76%
-

FAQ

  • What is Halozyme Therapeutics annual gross profit margin?
  • What is the all time high annual gross margin for Halozyme Therapeutics?
  • What is Halozyme Therapeutics annual gross margin year-on-year change?
  • What is Halozyme Therapeutics quarterly gross profit margin?
  • What is the all time high quarterly gross margin for Halozyme Therapeutics?
  • What is Halozyme Therapeutics quarterly gross margin year-on-year change?

What is Halozyme Therapeutics annual gross profit margin?

The current annual gross margin of HALO is 84.30%

What is the all time high annual gross margin for Halozyme Therapeutics?

Halozyme Therapeutics all-time high annual gross profit margin is 99.54%

What is Halozyme Therapeutics annual gross margin year-on-year change?

Over the past year, HALO annual gross profit margin has changed by +7.50% (+9.77%)

What is Halozyme Therapeutics quarterly gross profit margin?

The current quarterly gross margin of HALO is 81.73%

What is the all time high quarterly gross margin for Halozyme Therapeutics?

Halozyme Therapeutics all-time high quarterly gross profit margin is 99.95%

What is Halozyme Therapeutics quarterly gross margin year-on-year change?

Over the past year, HALO quarterly gross profit margin has changed by -3.81% (-4.45%)
On this page